137 related articles for article (PubMed ID: 22555526)
1. Population-based prevalence of abnormal cervical cytology findings and local risk factors in Ibadan, Nigeria: implications for cervical cancer control programs and human papilloma virus immunization.
Thomas JO; Ojemakinde KO; Ajayi IO; Omigbodun AO; Fawole OI; Oladepo O
Acta Cytol; 2012; 56(3):251-8. PubMed ID: 22555526
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and risk factors for human papillomavirus DNA in cervical cytology.
Kasap B; Yetimalar H; Keklik A; Yildiz A; Cukurova K; Soylu F
Eur J Obstet Gynecol Reprod Biol; 2011 Nov; 159(1):168-71. PubMed ID: 21764503
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of cervical cytological abnormalities in Turkish population.
Atilgan R; Celik A; Boztosun A; Ilter E; Yalta T; Ozercan R
Indian J Pathol Microbiol; 2012; 55(1):52-5. PubMed ID: 22499301
[TBL] [Abstract][Full Text] [Related]
4. Risk of invasive cervical cancer after atypical glandular cells in cervical screening: nationwide cohort study.
Wang J; Andrae B; Sundström K; Ström P; Ploner A; Elfström KM; Arnheim-Dahlström L; Dillner J; Sparén P
BMJ; 2016 Feb; 352():i276. PubMed ID: 26869597
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for cervical neoplasia in Denmark.
Kjaer SK
APMIS Suppl; 1998; 80():1-41. PubMed ID: 9693662
[TBL] [Abstract][Full Text] [Related]
6. [Prevalence of epithelial squamous cell abnormalities and associated factors in women of a rural town of Colombia].
Grisales H; Vanegas AP; Gaviria AM; Castaño J; Mora MA; Borrero M; Rojas C; Arbeláez MP; Sánchez GI
Biomedica; 2008 Jun; 28(2):271-83. PubMed ID: 18719718
[TBL] [Abstract][Full Text] [Related]
7. European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1.
Jordan J; Arbyn M; Martin-Hirsch P; Schenck U; Baldauf JJ; Da Silva D; Anttila A; Nieminen P; Prendiville W
Cytopathology; 2008 Dec; 19(6):342-54. PubMed ID: 19040546
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus cervical infection and associated risk factors in a region of Argentina with a high incidence of cervical carcinoma.
Tonon SA; Picconi MA; Zinovich JB; Liotta DJ; Bos PD; Galuppo JA; Alonio LV; Ferreras JA; Teyssié AR
Infect Dis Obstet Gynecol; 1999; 7(5):237-43. PubMed ID: 10524669
[TBL] [Abstract][Full Text] [Related]
9. Human papillomavirus DNA detection in cervical specimens by hybrid capture: correlation with cytologic and histologic diagnoses of squamous intraepithelial lesions of the cervix.
Hall S; Lörincz A; Shah F; Sherman ME; Abbas F; Paull G; Kurman RJ; Shah KV
Gynecol Oncol; 1996 Sep; 62(3):353-9. PubMed ID: 8812532
[TBL] [Abstract][Full Text] [Related]
10. Prevaccination distribution of human papillomavirus types in women attending at cervical cancer screening in Belgium.
Arbyn M; Benoy I; Simoens C; Bogers J; Beutels P; Depuydt C
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):321-30. PubMed ID: 19124515
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and determinants of cervical cytology use in an urban sample of Portuguese women.
Alves C; Alves L; Lunet N
Eur J Cancer Prev; 2009 Nov; 18(6):482-8. PubMed ID: 19734793
[TBL] [Abstract][Full Text] [Related]
12. Cervical cancer screening in a rural population of Zimbabwe.
Thistle PJ; Chirenje ZM
Cent Afr J Med; 1997 Sep; 43(9):246-51. PubMed ID: 9509642
[TBL] [Abstract][Full Text] [Related]
13. The significance of atypical glandular cells on routine cervical cytologic testing in a community-based population.
Chin AB; Bristow RE; Korst LM; Walts A; Lagasse LD
Am J Obstet Gynecol; 2000 Jun; 182(6):1278-82. PubMed ID: 10871439
[TBL] [Abstract][Full Text] [Related]
14. Risk of invasive cervical cancer after Pap smears: the protective effect of multiple negatives.
Coldman A; Phillips N; Kan L; Matisic J; Benedet L; Towers L
J Med Screen; 2005; 12(1):7-11. PubMed ID: 15814014
[TBL] [Abstract][Full Text] [Related]
15. Expression of the MN antigen in cervical papanicolaou smears is an early diagnostic biomarker of cervical dysplasia.
Liao SY; Stanbridge EJ
Cancer Epidemiol Biomarkers Prev; 1996 Jul; 5(7):549-57. PubMed ID: 8827360
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus prevalence and type distribution in 3603 HIV-positive and HIV-negative women in the general population of Tanzania: the PROTECT study.
Dartell M; Rasch V; Kahesa C; Mwaiselage J; Ngoma T; Junge J; Gernow A; Ejlersen SF; Munk C; Iftner T; Kjaer SK
Sex Transm Dis; 2012 Mar; 39(3):201-8. PubMed ID: 22337107
[TBL] [Abstract][Full Text] [Related]
17. Association between concurrent genital bleeding and cervical cancer: a cross-sectional study.
Xavier-Júnior JC; Vale DB; Zeferino LC; Dufloth RM
Acta Obstet Gynecol Scand; 2015 Sep; 94(9):949-53. PubMed ID: 26033639
[TBL] [Abstract][Full Text] [Related]
18. Cervical cytopathological changes in pregnancy: An experience from a low resource setting.
Rasheed FA; Yakasai IA; Takai IU; Yusuf I; Ibrahim UM
Ann Afr Med; 2021; 20(3):212-221. PubMed ID: 34558451
[TBL] [Abstract][Full Text] [Related]
19. Assessment of cervical cytological data in Albanian females.
Filipi K; Xhani A
Asian Pac J Cancer Prev; 2014; 15(5):2129-32. PubMed ID: 24716945
[TBL] [Abstract][Full Text] [Related]
20. Smear patterns and spectrum of premalignant and malignant cervical epithelial lesions in postmenopausal Indian women: a hospital-based study.
Ansari M; Mehdi G; Arif SH; Ansari H; Khan T
Diagn Cytopathol; 2012 Nov; 40(11):976-83. PubMed ID: 21538964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
